1Camm AJ.Kirchhof P,Lip GY,et al.Guidelines for the management of atrial fibrillation:The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J] Eur Heart J.[Epub ahead of print].
2Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation:full text:a report of the American College of Cardiology /American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation)developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J].Europace,2006,8(9):651-745.
4Iqba MB, Taneja AK, Gregory, et al. Recent developments in atrial fibrillation, full. British Medical Journal ,2005,300:238-243.
5Fauchier L, Pierre B, de Labriolle A, et al. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coil Cardiol,2008 ,51:828-835.
6Asghar O,Alam U,Hayat SA. Obesity,Diabetes and Atrial Fibrillation;Epidemiology,Mechanisms and Interventions[J].Curr Cardiol Rev,2012.
7Strobeck JE. Stroke prevention in atrial fibrillation:managing the risks in light of new oral anticoagulants[J].{H}Cardiovascular Drugs and Therapy,2012,(04):331-338.
8Fauchier L,Pierre B,de Labriolle A. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials[J].{H}Journal of the America College of Cardiology,2008,(08):828-835.
9Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study [J]. Stroke, 1991,22(8) :983-988.
10Lau DH, Kalman J, Sanders P, et al. Management of recent- onset sustained atrial fibrillation: pharmacologic and nonpharmacologic strategies [J]. Clin Ther, 2014, 36 (9): 1151-1159.
